48,830
edits
(→IHC) |
|||
Line 94: | Line 94: | ||
*CD30 -ve. | *CD30 -ve. | ||
**+ve in embryonal carcinoma. | **+ve in embryonal carcinoma. | ||
ISUP consensus for seminoma versus choriocarcinoma:<ref name=pmid25025364>{{Cite journal | last1 = Amin | first1 = MB. | last2 = Epstein | first2 = JI. | last3 = Ulbright | first3 = TM. | last4 = Humphrey | first4 = PA. | last5 = Egevad | first5 = L. | last6 = Montironi | first6 = R. | last7 = Grignon | first7 = D. | last8 = Trpkov | first8 = K. | last9 = Lopez-Beltran | first9 = A. | title = Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the international society of urological pathology consensus conference. | journal = Am J Surg Pathol | volume = 38 | issue = 8 | pages = 1017-22 | month = Aug | year = 2014 | doi = 10.1097/PAS.0000000000000254 | PMID = 25025364 }}</ref> | |||
*OCT4 (uniformily) +ve. | |||
**Choriocarcinoma = patchy staining. | |||
Additional notes: | Additional notes: |
edits